Breakpoints and pharmacokinetic-pharmacodynamic theory for respiratory infections and sepsis

Japanese Journal of Chemotherapy

Volumn 60, Issue 1, 2012, Pages 12-17

  Hiramatsu, Kazufumi ^a   Kadota, Jun Ichi ^b  

^a OITA UNIVERSITY HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Breakpoint; PK PD; Respiratory infection; Sepsis

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHEMOTHERAPY; MINIMUM INHIBITORY CONCENTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; RESPIRATORY TRACT INFECTION; SEPSIS; TREATMENT OUTCOME;

EID: 84861414968     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chemotherapy 1994; 42: 905-14
2. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing Twenty-first informational supplement. M100-S21, CLSI, Wayne, PA, 2011
3. Saito A: Clinical breakpoints for antimicrobial agents in pulmonary infections and sepsis: report of the committee for Japanese standards for antimicrobial susceptibility testing for bacteria. J Infect Chemother 1995; 1: 83-8
4. European Committee on Antimicrobial Susceptibility Testing: Breakpoint tables for interpretation of MICs and zone diameters. Ver 1.3, EUCAST, 2011
5. Craig WA: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1-10
6. Breakpoints in in-vitro antibiotic sensitivity testing. Report by a working party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 1988; 21: 701-10
7. http://www.chemotherapy.or.jp/journal/reports/breakpoint-data.html